Phase 1, Safety and Tolerability Study of XmAb541 in Advanced Solid Tumors
Xencor, Inc.
Xencor, Inc.
SWOG Cancer Research Network
University Hospital, Clermont-Ferrand
National Institutes of Health Clinical Center (CC)
University College Cork
Kaiser Permanente
AstraZeneca
Context Therapeutics Inc.
Indiana University
University of Arizona
BioNTech SE
Indiana University
Jonsson Comprehensive Cancer Center
Memorial Sloan Kettering Cancer Center
Loma Linda University
City of Hope Medical Center
University of Nebraska
Swiss Cancer Institute
Vastra Gotaland Region
Cantonal Hospital of St. Gallen
Ordu University
University of Southern California
St. Olavs Hospital
University Medical Center Groningen
University of Southern California
West China Hospital
Massive Bio, Inc.
UNC Lineberger Comprehensive Cancer Center
University of Southern California
University of Arizona
University Medical Center Groningen
Washington University School of Medicine
Jonsson Comprehensive Cancer Center
University of Texas Southwestern Medical Center
Indiana University
Western University, Canada
Jagiellonian University
The University of Texas Health Science Center at San Antonio
BioNTech SE
University Medical Center Groningen
Columbia University
University Medical Center Groningen
University of California, Irvine
Mayo Clinic
University Health Network, Toronto
City of Hope Medical Center
Hitit University
Centre Leon Berard
University Health Network, Toronto
Seagen Inc.